Key Takeaway: Oculis has published a Notification of Major Changes in Voting Rights. This announcement details significant amendments related to the rights of shareholders in the company. Specific changes and their implications are expected to be outlined in the attached document, providing shareholders with key information moving forward.
Price reaction · baseline $22.74 (2025-01-17 close) · hit after-hours · clean, no other OCS news in the window
day 0 close · peak
-0.4%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
3.8%
average across 4 past catalysts
Lead asset
Privosegtor
Phase 3 · Optic Neuritis
Full Press Release Details
ZUG, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Attached is a Notification of Major Changes in Voting Rights.
Notification of Major Changes in Voting Rights - slandsbanki (21 Jan 2025)
Attachments
Notification of Major Changes in Voting Rights - slandsbanki (21 Jan 2025)...
Frequently Asked Questions
What is the date of the major changes notification?
The notification was issued on January 21, 2025.
What company is associated with the voting rights notification?
The notification pertains to Slandsbanki.
Where is Slandsbanki located?
Slandsbanki is based in Zug, Switzerland.
What type of document is attached to the notification?
It includes a Notification of Major Changes in Voting Rights.